| Comparison of two methods for enumerating circulating tumor cells in carcinoma patients M Balic, N Dandachi, G Hofmann, H Samonigg, H Loibner, A Obwaller, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2005 | 190 | 2005 |
| Co‐expression of tenascin‐C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological … N Dandachi, C Hauser‐Kronberger, E More, B Wiesener, GW Hacker, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 162 | 2001 |
| Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue K Biedermann, N Dandachi, M Trattner, G Vogl, H Doppelmayr, E Moré, ... Journal of clinical microbiology 42 (8), 3758-3765, 2004 | 122 | 2004 |
| Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors M Pichler, M Balic, E Stadelmeyer, C Ausch, M Wild, C Guelly, ... The Journal of Molecular Diagnostics 11 (2), 140-147, 2009 | 112 | 2009 |
| Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer W Schippinger, P Regitnig, N Dandachi, KD Wernecke, T Bauernhofer, ... Virchows Archiv 449, 24-30, 2006 | 112 | 2006 |
| Prognostic factors in surgically treated stage Ib–IIb cervical carcinomas with special emphasis on the importance of tumor volume M Trattner, AH Graf, S Lax, R Forstner, N Dandachi, J Haas, H Pickel, ... Gynecologic oncology 82 (1), 11-16, 2001 | 100 | 2001 |
| High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis M Balic, M Pichler, J Strutz, E Heitzer, C Ausch, H Samonigg, RJ Cote, ... The Journal of Molecular Diagnostics 11 (2), 102-108, 2009 | 77 | 2009 |
| Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy C Suppan, V Bjelic-Radisic, M La Garde, A Groselj-Strele, K Eberhard, ... BMC cancer 15, 1-8, 2015 | 70 | 2015 |
| Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer C Hauser-Kronberger, N Dandachi Journal of molecular histology 35, 647-653, 2004 | 69 | 2004 |
| Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells M Balic, N Rapp, S Stanzer, H Lin, J Strutz, J Szkandera, MG Daidone, ... Applied immunohistochemistry & molecular morphology 19 (1), 33-40, 2011 | 54 | 2011 |
| Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer T Bauernhofer, S Zenahlik, G Hofmann, M Balic, M Resel, R Pirchmoser, ... Oncology reports 13 (2), 179-184, 2005 | 53 | 2005 |
| Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD) P Stiegler, M Sereinigg, A Puntschart, A Bradatsch, T Seifert-Held, ... Journal of translational medicine 11, 1-12, 2013 | 50 | 2013 |
| Micrometastasis: detection methods and clinical importance M Balic, A Williams, N Dandachi, RJ Cote Cancer Biomarkers 9 (1-6), 397-419, 2011 | 50 | 2011 |
| Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization C Ausch, V Buxhofer-Ausch, C Oberkanins, B Holzer, M Minai-Pour, ... The Journal of Molecular Diagnostics 11 (6), 508-513, 2009 | 47 | 2009 |
| Genetic and epigenetic analysis of putative breast cancer stem cell models M Balic, D Schwarzenbacher, S Stanzer, E Heitzer, M Auer, JB Geigl, ... BMC cancer 13, 1-15, 2013 | 46 | 2013 |
| Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients N Dandachi, M Balic, S Stanzer, M Halm, M Resel, TA Hinterleitner, ... The Journal of Molecular Diagnostics 7 (5), 631-637, 2005 | 46 | 2005 |
| The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer W Schippinger, N Dandachi, P Regitnig, G Hofmann, M Balic, R Neumann, ... American journal of clinical pathology 128 (4), 630-637, 2007 | 40 | 2007 |
| Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines E More, T Fellner, H Doppelmayr, C Hauser-Kronberger, N Dandachi, ... Journal of endocrinology 176 (1), 83-94, 2003 | 40 | 2003 |
| Validation of residual cancer burden as prognostic factor for breast cancer patients after neoadjuvant therapy HD Müller, F Posch, C Suppan, U Bargfrieder, M Gumpoldsberger, ... Annals of surgical oncology 26, 4274-4283, 2019 | 38 | 2019 |
| Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1 E Heitzer, M Artl, M Filipits, M Resel, R Graf, B Weißenbacher, S Lax, ... Modern Pathology 27 (6), 906-915, 2014 | 33 | 2014 |
